Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
Identifieur interne : 000512 ( France/Analysis ); précédent : 000511; suivant : 000513Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
Auteurs : Alberto Albanese [Italie] ; Ubaldo Bonuccelli [Italie] ; Christine Brefel [France] ; K. Ray Chaudhuri [Royaume-Uni] ; Carlo Colosimo [Italie] ; Tobias Eichhorn [Allemagne] ; Eldad Melamed [Israël] ; Pierre Pollak [France] ; Teus Van Laar [Pays-Bas] ; Mario Zappia [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2001-03.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme, Recommandation.
English descriptors
- KwdEn :
- Agonist, Antiparkinson agent, Apomorphine (administration & dosage), Apomorphine (diagnostic use), Apomorphine (pharmacology), Chemotherapy, Consensus conference, Corpus Striatum (drug effects), Decision Making, Diagnosis, Domperidone (administration & dosage), Domperidone (diagnostic use), Domperidone (pharmacology), Dopamine Agonists (administration & dosage), Dopamine Agonists (diagnostic use), Dopamine Agonists (pharmacology), Dopamine Antagonists (administration & dosage), Dopamine Antagonists (diagnostic use), Dopamine Antagonists (pharmacology), Dopamine agonist, Dopamine receptor, Drug Administration Schedule, Guidelines as Topic, Human, Humans, Levodopa, Levodopa (administration & dosage), Levodopa (diagnostic use), Levodopa (pharmacology), Parkinson Disease (diagnosis), Parkinson disease, Pharmacologic test, Recommendation, Substantia Nigra (drug effects), Time Factors, Treatment, apomorphine, diagnosis, levodopa, treatment.
- MESH :
- chemical , administration & dosage : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- chemical , diagnostic use : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- chemical , pharmacology : Apomorphine, Domperidone, Dopamine Agonists, Dopamine Antagonists, Levodopa.
- diagnosis : Parkinson Disease.
- drug effects : Corpus Striatum, Substantia Nigra.
- Decision Making, Drug Administration Schedule, Guidelines as Topic, Humans, Time Factors.
Abstract
Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.
Url:
DOI: 10.1002/mds.1069
Affiliations:
- Allemagne, France, Israël, Italie, Pays-Bas, Royaume-Uni
- Angleterre, Auvergne-Rhône-Alpes, Grand Londres, Hollande-Méridionale, Latium, Rhône-Alpes
- Grenoble, Leyde, Londres, Rome, Toulouse
- Centre hospitalier universitaire Grenoble Alpes, Université de Rome « La Sapienza »
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002A93
- to stream Istex, to step Curation: 002A93
- to stream Istex, to step Checkpoint: 003064
- to stream Main, to step Merge: 006D19
- to stream PascalFrancis, to step Corpus: 002A25
- to stream PascalFrancis, to step Curation: 000296
- to stream PascalFrancis, to step Checkpoint: 002A28
- to stream Main, to step Merge: 006F27
- to stream PubMed, to step Corpus: 003D91
- to stream PubMed, to step Curation: 003D91
- to stream PubMed, to step Checkpoint: 003D80
- to stream Ncbi, to step Merge: 000460
- to stream Ncbi, to step Curation: 000460
- to stream Ncbi, to step Checkpoint: 000460
- to stream Main, to step Merge: 006A82
- to stream Main, to step Curation: 004836
- to stream Main, to step Exploration: 004836
- to stream France, to step Extraction: 000512
Links to Exploration step
ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title><author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name></author><author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name></author><author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name></author><author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name></author><author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name></author><author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name></author><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name></author><author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name><affiliation><country>France</country><placeName><settlement type="city">Grenoble</settlement><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName><orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName></affiliation></author><author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name></author><author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E</idno><date when="2001" year="2001">2001</date><idno type="doi">10.1002/mds.1069</idno><idno type="url">https://api.istex.fr/document/3638D905253CBADE5F33953F6B488F265CEAEE7E/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002A93</idno><idno type="wicri:Area/Istex/Curation">002A93</idno><idno type="wicri:Area/Istex/Checkpoint">003064</idno><idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno><idno type="wicri:Area/Main/Merge">006D19</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:01-0333009</idno><idno type="wicri:Area/PascalFrancis/Corpus">002A25</idno><idno type="wicri:Area/PascalFrancis/Curation">000296</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">002A28</idno><idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno><idno type="wicri:Area/Main/Merge">006F27</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:11295770</idno><idno type="wicri:Area/PubMed/Corpus">003D91</idno><idno type="wicri:Area/PubMed/Curation">003D91</idno><idno type="wicri:Area/PubMed/Checkpoint">003D80</idno><idno type="wicri:Area/Ncbi/Merge">000460</idno><idno type="wicri:Area/Ncbi/Curation">000460</idno><idno type="wicri:Area/Ncbi/Checkpoint">000460</idno><idno type="wicri:doubleKey">0885-3185:2001:Albanese A:consensus:statement:on</idno><idno type="wicri:Area/Main/Merge">006A82</idno><idno type="wicri:Area/Main/Curation">004836</idno><idno type="wicri:Area/Main/Exploration">004836</idno><idno type="wicri:Area/France/Extraction">000512</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease</title><author><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Neurologia, Università Cattolica, and Istituto Nazionale Neurologico, Milano</wicri:regionArea><wicri:noRegion>Milano</wicri:noRegion></affiliation></author><author><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Università di Pisa, Pisa</wicri:regionArea><wicri:noRegion>Pisa</wicri:noRegion></affiliation></author><author><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Laboratoire de Pharmacologie Médical et Clinique, INSERM U455, Toulouse</wicri:regionArea><placeName><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name><affiliation wicri:level="3"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, King's College Hospital, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region></placeName></affiliation></author><author><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name><affiliation wicri:level="4"><country xml:lang="fr">Italie</country><wicri:regionArea>Dipartimento di Scienze Neurologiche, Università La Sapienza, Roma</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><orgName type="university">Université de Rome « La Sapienza »</orgName></affiliation></author><author><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Klinik für Neurologie, Zentrum für Nervenheilkunde, Philipps‐Universität Marburg</wicri:regionArea><wicri:noRegion>Philipps‐Universität Marburg</wicri:noRegion><wicri:noRegion>Philipps‐Universität Marburg</wicri:noRegion></affiliation></author><author><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Neurology, Beilinson Medical Centre, Sackler Medical School, Tel‐Aviv</wicri:regionArea><wicri:noRegion>Tel‐Aviv</wicri:noRegion></affiliation></author><author><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name><affiliation wicri:level="1"><country xml:lang="fr">France</country><wicri:regionArea>Service de Neurologie, Université J. Fourier, Grenoble</wicri:regionArea><placeName><settlement type="city">Grenoble</settlement></placeName><placeName><settlement type="city">Grenoble</settlement><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region></placeName><orgName type="hospital" n="4">Centre hospitalier universitaire Grenoble Alpes</orgName></affiliation></author><author><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurology, Leiden University Medical Centre, Leiden</wicri:regionArea><placeName><settlement type="city">Leyde</settlement><region nuts="2" type="province">Hollande-Méridionale</region></placeName></affiliation></author><author><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Università di Catanzaro, Catanzaro</wicri:regionArea><wicri:noRegion>Catanzaro</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>John Wiley & Sons, Inc.</publisher><pubPlace>New York</pubPlace><date type="published" when="2001-03">2001-03</date><biblScope unit="vol">16</biblScope><biblScope unit="issue">2</biblScope><biblScope unit="page" from="197">197</biblScope><biblScope unit="page" to="201">201</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">3638D905253CBADE5F33953F6B488F265CEAEE7E</idno><idno type="DOI">10.1002/mds.1069</idno><idno type="ArticleID">MDS1069</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Agonist</term><term>Antiparkinson agent</term><term>Apomorphine (administration & dosage)</term><term>Apomorphine (diagnostic use)</term><term>Apomorphine (pharmacology)</term><term>Chemotherapy</term><term>Consensus conference</term><term>Corpus Striatum (drug effects)</term><term>Decision Making</term><term>Diagnosis</term><term>Domperidone (administration & dosage)</term><term>Domperidone (diagnostic use)</term><term>Domperidone (pharmacology)</term><term>Dopamine Agonists (administration & dosage)</term><term>Dopamine Agonists (diagnostic use)</term><term>Dopamine Agonists (pharmacology)</term><term>Dopamine Antagonists (administration & dosage)</term><term>Dopamine Antagonists (diagnostic use)</term><term>Dopamine Antagonists (pharmacology)</term><term>Dopamine agonist</term><term>Dopamine receptor</term><term>Drug Administration Schedule</term><term>Guidelines as Topic</term><term>Human</term><term>Humans</term><term>Levodopa</term><term>Levodopa (administration & dosage)</term><term>Levodopa (diagnostic use)</term><term>Levodopa (pharmacology)</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson disease</term><term>Pharmacologic test</term><term>Recommendation</term><term>Substantia Nigra (drug effects)</term><term>Time Factors</term><term>Treatment</term><term>apomorphine</term><term>diagnosis</term><term>levodopa</term><term>treatment</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Apomorphine</term><term>Domperidone</term><term>Dopamine Agonists</term><term>Dopamine Antagonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>Apomorphine</term><term>Domperidone</term><term>Dopamine Agonists</term><term>Dopamine Antagonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Apomorphine</term><term>Domperidone</term><term>Dopamine Agonists</term><term>Dopamine Antagonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Corpus Striatum</term><term>Substantia Nigra</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Decision Making</term><term>Drug Administration Schedule</term><term>Guidelines as Topic</term><term>Humans</term><term>Time Factors</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Agoniste</term><term>Antiparkinsonien</term><term>Apomorphine</term><term>Chimiothérapie</term><term>Conférence consensus</term><term>Diagnostic</term><term>Epreuve pharmacologique</term><term>Homme</term><term>Lévodopa</term><term>Parkinson maladie</term><term>Recommandation</term><term>Récepteur dopaminergique</term><term>Stimulant dopaminergique</term><term>Traitement</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term><term>Recommandation</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Available evidence on the practice of acute pharmacological challenge tests in parkinsonian patients was reviewed by a committee of experts, which achieved a general consensus. The published data deal mainly with the acute administration of levodopa and apomorphine in Parkinson's disease. Such challenge may serve different purposes, e.g., research, diagnosis, or tailoring of treatment. Unique protocols describing the clinical setting and practice parameters are not available. The present paper describes the scientific background and supplies practical guidelines, whenever possible, to perform and evaluate acute challenge tests in parkinsonian syndromes. With the appropriate indication and setting, acute challenge tests are useful in diagnosis and therapy of Parkinson's disease and related disorders. © 2001 Movement Disorder Society.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>France</li><li>Israël</li><li>Italie</li><li>Pays-Bas</li><li>Royaume-Uni</li></country><region><li>Angleterre</li><li>Auvergne-Rhône-Alpes</li><li>Grand Londres</li><li>Hollande-Méridionale</li><li>Latium</li><li>Rhône-Alpes</li></region><settlement><li>Grenoble</li><li>Leyde</li><li>Londres</li><li>Rome</li><li>Toulouse</li></settlement><orgName><li>Centre hospitalier universitaire Grenoble Alpes</li><li>Université de Rome « La Sapienza »</li></orgName></list><tree><country name="Italie"><noRegion><name sortKey="Albanese, Alberto" sort="Albanese, Alberto" uniqKey="Albanese A" first="Alberto" last="Albanese">Alberto Albanese</name></noRegion><name sortKey="Bonuccelli, Ubaldo" sort="Bonuccelli, Ubaldo" uniqKey="Bonuccelli U" first="Ubaldo" last="Bonuccelli">Ubaldo Bonuccelli</name><name sortKey="Colosimo, Carlo" sort="Colosimo, Carlo" uniqKey="Colosimo C" first="Carlo" last="Colosimo">Carlo Colosimo</name><name sortKey="Zappia, Mario" sort="Zappia, Mario" uniqKey="Zappia M" first="Mario" last="Zappia">Mario Zappia</name></country><country name="France"><noRegion><name sortKey="Brefel, Christine" sort="Brefel, Christine" uniqKey="Brefel C" first="Christine" last="Brefel">Christine Brefel</name></noRegion><name sortKey="Pollak, Pierre" sort="Pollak, Pierre" uniqKey="Pollak P" first="Pierre" last="Pollak">Pierre Pollak</name></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Chaudhuri, K Ray" sort="Chaudhuri, K Ray" uniqKey="Chaudhuri K" first="K. Ray" last="Chaudhuri">K. Ray Chaudhuri</name></region></country><country name="Allemagne"><noRegion><name sortKey="Eichhorn, Tobias" sort="Eichhorn, Tobias" uniqKey="Eichhorn T" first="Tobias" last="Eichhorn">Tobias Eichhorn</name></noRegion></country><country name="Israël"><noRegion><name sortKey="Melamed, Eldad" sort="Melamed, Eldad" uniqKey="Melamed E" first="Eldad" last="Melamed">Eldad Melamed</name></noRegion></country><country name="Pays-Bas"><region name="Hollande-Méridionale"><name sortKey="Van Laar, Teus" sort="Van Laar, Teus" uniqKey="Van Laar T" first="Teus" last="Van Laar">Teus Van Laar</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000512 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000512 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:3638D905253CBADE5F33953F6B488F265CEAEE7E
|texte= Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |